We are live on ! Find out more
ENTA icon

Enanta Pharmaceuticals
ENTA

131 hedge funds and large institutions have $621M invested in Enanta Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 55 increasing their positions, 27 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

104% more repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 27

100% more funds holding in top 10

Funds holding in top 10: 2 → 4 (+2)

74% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 19

63% more capital invested

Capital invested by funds: $380M → $621M (+$241M)

12% more funds holding

Funds holding: 117 → 131 (+14)

11% more call options, than puts

Call options by funds: $1.55M | Put options by funds: $1.39M

Holders
131
Holders Change
+14
Holders Change %
+11.97%
% of All Funds
3.53%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.11%
New
33
Increased
55
Reduced
27
Closed
19
Calls
$1.55M
Puts
$1.39M
Net Calls
+$157K
Net Calls Change
+$971K

Top Buyers

Rank Fund Capital Flow
1
VOYA Investment Management
VOYA Investment Management
Georgia
+$14.5M
2
KAM
Krensavage Asset Management
New York
+$11M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$10.3M
4
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
+$9.32M
5
NI
Numeric Investors
Massachusetts
+$9.16M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$15.8M
2
CCM
Consonance Capital Management
New York
-$12.1M
3
Millennium Management
Millennium Management
New York
-$8.17M
4
SAM
Senzar Asset Management
New York
-$4.72M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$4.55M
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
26
Geode Capital Management
Massachusetts
$4.21M +$324K +8,322 +10%
TCM
27
Tieton Capital Management
Washington
$4.14M +$3.58M +92,080 New
LSV Asset Management
28
LSV Asset Management
Illinois
$4.11M +$3.55M +91,300 New
AL
29
AJO LP
Pennsylvania
$3.87M +$3.35M +86,060 New
SCP
30
Seizert Capital Partners
Michigan
$3.76M +$3.25M +83,605 New
QI
31
QS Investors
New York
$3.49M – – –
BBA
32
Baker Bros. Advisors
New York
$3.39M – – –
PA
33
Pinnacle Associates
New York
$3.29M +$2.84M +73,100 New
RFC
34
Russell Frank Company
Washington
$3.13M +$2.26M +57,979 +500%
TCIM
35
TIAA CREF Investment Management
New York
$3.1M +$424K +10,905 +19%
B
36
Bailard
California
$3.01M -$1.28M -33,000 -33%
USAA
37
United Services Automobile Association
Texas
$2.6M +$2.24M +57,700 New
BIM
38
BlackRock Investment Management
Delaware
$2.56M +$1.03M +26,467 +87%
BA
39
BlackRock Advisors
Delaware
$2.51M -$1.14M -29,353 -34%
GCP
40
GSA Capital Partners
United Kingdom
$2.38M -$342K -8,799 -14%
CIP
41
Convergence Investment Partners
Florida
$2.33M +$2.02M +51,840 New
AQR Capital Management
42
AQR Capital Management
Connecticut
$2.22M +$303K +7,786 +19%
BJ
43
BlackRock Japan
Japan
$2.21M -$62.9K -1,617 -3%
CS
44
Credit Suisse
Switzerland
$2.03M +$573K +14,732 +48%
CS
45
Candriam SCA
Luxembourg
$2.02M +$1.75M +45,000 New
Prudential Financial
46
Prudential Financial
New Jersey
$2.02M +$1.75M +44,970 New
PI
47
Putnam Investments
Massachusetts
$1.85M +$615K +15,798 +62%
Public Employees Retirement Association of Colorado
48
Public Employees Retirement Association of Colorado
Colorado
$1.73M – – –
GC
49
Guggenheim Capital
Illinois
$1.71M -$277K -7,132 -16%
FWCM
50
First Western Capital Management
California
$1.59M +$1.38M +35,350 New
1
2
3 4 5

ENTA Hedge Fund Activity: Q2 2015 in Review

131 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Enanta Pharmaceuticals (ENTA) for Q2 2015, worth a combined $621M — up 63% from $380M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new ENTA positions and 19 closed out — a net gain of 14 holders — while 55 added to existing stakes and 27 trimmed.

The largest buyer was VOYA Investment Management, opening a new position worth an estimated $14.5M. The largest seller was Fidelity Investments, cutting an estimated $15.8M.

  • 131 institutional investors held Enanta Pharmaceuticals (ENTA) as of Q2 2015, up from 117 in Q1 2015.
  • Funds reported $621M of Enanta Pharmaceuticals stock for Q2 2015, up 63% quarter-over-quarter.
  • 33 funds opened new Enanta Pharmaceuticals positions in Q2 2015 and 19 closed out, a net change of +14 holders.
  • The largest Enanta Pharmaceuticals buyer in Q2 2015 was VOYA Investment Management, an estimated $14.5M added.
  • The largest Enanta Pharmaceuticals seller in Q2 2015 was Fidelity Investments, an estimated $15.8M sold.

Based on aggregated 13F filings for Q2 2015.